Download
s40478-020-01000-w.pdf 2,23MB
WeightNameValue
1000 Titel
  • A comprehensive DNA panel next generation sequencing approach supporting diagnostics and therapy prediction in neurooncology
1000 Autor/in
  1. Lorenz, Julia |
  2. Rothhammer-Hampl, Tanja |
  3. Zoubaa, Saida |
  4. Bumes, Elisabeth |
  5. Pukrop, Tobias |
  6. Kölbl, Oliver |
  7. Corbacioglu, Selim |
  8. Schmidt, Nils O. |
  9. Proescholdt, Martin |
  10. Hau, Peter |
  11. Riemenschneider, Markus J. |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-08-05
1000 Erschienen in
1000 Quellenangabe
  • 8(1):124
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s40478-020-01000-w |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405456/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Recent updates in the classification of central nervous system (CNS) tumors have increased the need for molecular testing. Assessment of multiple alterations in parallel, complex combinations of gene sequence and chromosomal changes, as well as therapy prediction by identification of actionable mutations are the major challenges. We here report on a customized next generation sequencing (NGS)-based DNA panel assay that combines diagnostic and predictive testing and -as a comprehensive approach- allows for simultaneous single nucleotide variant (SNP) / small insertion/deletion (InDel), copy number variation (CNV) and loss of heterozygosity (LOH) detection. We analyzed formalin-fixed and paraffin-embedded (FFPE) DNA from a total of 104 patients with CNS tumors. After amplicon capture-based library preparation, sequencing was performed on the relatively cost-efficient Illiumina MiniSeq platform and evaluated with freely available bioinformatical tools. 57 genes for exonic SNP/InDel calling (19 of those in intronic regions for CNV analysis), 3 chromosomal arms and 4 entire chromosomes for CNV and LOH analysis were covered. Results were extensively validated. Our approach yielded high accuracy, sensitivity and specificity. It led to refined diagnoses in a relevant number of analyzed cases, reliably enabled complex subclassifications (e.g. for medulloblastomas) and identified actionable targets for clinical use. Thus, our single-platform approach is an efficient and powerful tool to comprehensively support molecular testing in neurooncology. Future functionality is guaranteed as novel upcoming biomarkers can be easily incorporated in a modular panel design.
1000 Sacherschließung
lokal Glioma
lokal Female [MeSH]
lokal High-Throughput Nucleotide Sequencing/methods [MeSH]
lokal Brain Neoplasms/genetics [MeSH]
lokal Adult [MeSH]
lokal Medulloblastoma
lokal Humans [MeSH]
lokal Medical Oncology/methods [MeSH]
lokal Precision Medicine/methods [MeSH]
lokal Next generation sequencing
lokal Glioblastoma
lokal Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH]
lokal Male [MeSH]
lokal Integrated diagnoses
lokal Research
lokal Biomarkers, Tumor/genetics [MeSH]
lokal Targeted therapy
lokal Neurology/methods [MeSH]
lokal Sequence Analysis, DNA [MeSH]
lokal Brain Neoplasms/drug therapy [MeSH]
lokal Molecular Targeted Therapy/methods [MeSH]
lokal Meningioma
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/TG9yZW56LCBKdWxpYQ==|https://frl.publisso.de/adhoc/uri/Um90aGhhbW1lci1IYW1wbCwgVGFuamE=|https://frl.publisso.de/adhoc/uri/Wm91YmFhLCBTYWlkYQ==|https://frl.publisso.de/adhoc/uri/QnVtZXMsIEVsaXNhYmV0aA==|https://frl.publisso.de/adhoc/uri/UHVrcm9wLCBUb2JpYXM=|https://frl.publisso.de/adhoc/uri/S8O2bGJsLCBPbGl2ZXI=|https://frl.publisso.de/adhoc/uri/Q29yYmFjaW9nbHUsIFNlbGlt|https://frl.publisso.de/adhoc/uri/U2NobWlkdCwgTmlscyBPLg==|https://frl.publisso.de/adhoc/uri/UHJvZXNjaG9sZHQsIE1hcnRpbg==|https://frl.publisso.de/adhoc/uri/SGF1LCBQZXRlcg==|https://frl.publisso.de/adhoc/uri/UmllbWVuc2NobmVpZGVyLCBNYXJrdXMgSi4=
1000 Hinweis
  • DeepGreen-ID: 10cf615565154357a647a1bc0e6236c5 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6452344.rdf
1000 Erstellt am 2023-05-12T14:54:38.176+0200
1000 Erstellt von 322
1000 beschreibt frl:6452344
1000 Zuletzt bearbeitet Mon Oct 23 15:50:12 CEST 2023
1000 Objekt bearb. Mon Oct 23 15:50:12 CEST 2023
1000 Vgl. frl:6452344
1000 Oai Id
  1. oai:frl.publisso.de:frl:6452344 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source